"What has been missing is the patient's perspective," says one industry consultant. The future of clinical pathways is patient-centric: an approach that balances the long-standing focus on ...
Caroline Block, MD: For the way we construct our Clinical Pathways, we focus on what the specific situation is. From the beginning, is this adjuvant treatment, or is it DCIS [ductal carcinoma in situ] ...
An administrator in the Geisinger Cancer Institute discusses the rollout of ClinicalPath. Clinical pathways in cancer care are beyond the “new” phase, but oncology practices and health systems are ...
Linda Bosserman, M.D., joined City of Hope in Los Angeles nine years ago as a medical oncologist specializing in breast cancer and value-based care. During her 26 years in private practice, prior to ...
In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...
An update from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics has provided a regulatory update on NUZ-001, its ...
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback